Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segment Elevation Myocardial Infarction Patients

NCT05246215 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05246215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segment Elevation Myocardial Infarction Patients
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2022
Completion date
March 1, 2026
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hf - heart failure, st elevation myocardial infarction, stable angina